New weight loss medication may help lower blood pressure in adults with obesity
February 05, 2024
February 05, 2024
DALLAS, Texas, Feb. 5 [Category: Health Care] -- The American Heart Association issued the following news release:
Research Highlights:
The weight loss medication tirzepatide significantly lowered the systolic blood pressure of nearly 500 adults who had obesity and took the medication for 36 weeks, or about eight months, in a subset of an international clinical trial.
Participants taking 5 mg of tirzepatide had an average systolic blood pressure reduction o . . .
Research Highlights:
The weight loss medication tirzepatide significantly lowered the systolic blood pressure of nearly 500 adults who had obesity and took the medication for 36 weeks, or about eight months, in a subset of an international clinical trial.
Participants taking 5 mg of tirzepatide had an average systolic blood pressure reduction o . . .